Methods of treating mutant lymphomas
US11857535B2 · kind B2 · utility
1Cited by
5References
30Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 29, 2021 |
| Grant date | Jan 2, 2024 |
| Priority date | — |
| Expiry date | Jul 29, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of treating MYD88-mutant B-cell lymphomas using IRAK4 degrader.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.